LXRX
Lexicon Pharmaceuticals Inc
Price:  
0.90 
USD
Volume:  
1,645,573.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

LXRX Relative Valuation

-1197.2%
Upside

As of 2025-07-06, the Relative Valuation of Lexicon Pharmaceuticals Inc (LXRX) is (9.89) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.90 USD, the upside of Lexicon Pharmaceuticals Inc based on Relative Valuation is -1197.2%.

The range of the Relative Valuation is (6.69) - (13.18) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 13.1x - 27.0x 20.0x
Forward P/E multiples 13.7x - 27.2x 20.4x
Fair Price (6.69) - (13.18) (9.89)
Upside -842.3% - -1562.9% -1197.2%
0.90 USD
Stock Price
(9.89) USD
Fair Price

LXRX Relative Valuation - Historical P/E Data

Date P/E
2025-07-03 -1.85
2025-07-02 -1.88
2025-07-01 -1.81
2025-06-30 -1.94
2025-06-27 -1.68
2025-06-26 -1.90
2025-06-25 -1.84
2025-06-24 -1.58
2025-06-23 -1.50
2025-06-20 -1.54
2025-06-18 -1.53
2025-06-17 -1.48
2025-06-16 -1.37
2025-06-13 -1.38
2025-06-12 -1.43
2025-06-11 -1.44
2025-06-10 -1.44
2025-06-09 -1.53
2025-06-06 -1.57
2025-06-05 -1.47
2025-06-04 -1.35
2025-06-03 -1.29
2025-06-02 -1.27
2025-05-30 -1.28
2025-05-29 -1.35
2025-05-28 -1.43
2025-05-27 -1.41
2025-05-23 -1.35
2025-05-22 -1.35
2025-05-21 -1.26
2025-05-20 -1.17
2025-05-19 -1.14
2025-05-16 -1.10
2025-05-15 -1.09
2025-05-14 -1.09
2025-05-13 -1.29
2025-05-12 -1.38
2025-05-09 -1.44
2025-05-08 -1.41
2025-05-07 -1.40
2025-05-06 -1.34
2025-05-05 -1.47
2025-05-02 -1.39
2025-05-01 -1.48
2025-04-30 -1.50
2025-04-29 -1.37
2025-04-28 -1.41
2025-04-25 -1.45
2025-04-24 -1.44
2025-04-23 -1.38